NYSEARCA:GERM Amplify Treatments, Testing and Advancements ETF (GERM) Price, Holdings, & News → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free GERM Stock Alerts $19.56 -0.34 (-1.71%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Today's Range$19.36▼$19.8950-Day Range$16.34▼$20.2052-Week Range$15.67▼$21.48Volume2,100 shsAverage Volume2,255 shsMarket Capitalization$10.76 millionAssets Under Management$10.98 millionDividend Yield0.72%Net Expense Ratio0.68% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Amplify Treatments, Testing and Advancements ETF alerts: Email Address About Amplify Treatments, Testing and Advancements ETF (NYSEARCA:GERM)The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group.Read More GERM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GERM ETF News HeadlinesFebruary 11, 2024 | thestreet.comETFMG Treatments Testing and Advancements ETFDecember 28, 2023 | msn.comETFMG Treatments, Testing and Advancements ETF declares $0.0522 dividendAugust 25, 2023 | seekingalpha.comGERM ETFMG Treatments, Testing and Advancements ETFJune 23, 2023 | msn.comETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0600April 25, 2023 | usatoday.comCutting-edge advances in cancer treatment are underway. Here are 3 that could change lives.April 11, 2023 | msn.comJP Morgan Maintains Moderna (MRNA) Neutral RecommendationMarch 24, 2023 | marketwatch.comLactose Intolerance Treatment Market Growth by 2031March 8, 2023 | marketwatch.comLatest "Blood Culture Test Market" Insights, Trends & Future Development Status Recorded During 2023-2028See More Headlines Receive GERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplify Treatments, Testing and Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAmplify Fund NameAmplify Treatments, Testing and Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GERM Inception Date6/17/2020 Fund ManagerCharles Ragauss, Qiao Duan WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkPrime Treatments, Testing and Advancements Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings57 Fund Statistics Assets Under Management$10.98 million Average Daily Volume$0.00 Discount/Premium-0.07% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorAmplify Investments LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares550,000Beta1.08 Creation Unit50,000 Creation Fee$300.00 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Ad Traders AgencyHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades Amplify Treatments, Testing and Advancements ETF ExpensesTypeGERMTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.68%0.57%0.54%0.50%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.68%0.72%0.70%0.73%0.70%Fee Waiver0.00%-0.76%-0.54%-0.68%-0.56%Net Expense0.68%0.59%0.60%0.58%0.58% Amplify Treatments, Testing and Advancements ETF (GERM) Holdings & ExposureTop 10 GERM HoldingsModerna(NASDAQ:MRNA)Holding Weight: 10.24%Quest Diagnostics(NYSE:DGX)Holding Weight: 6.41%BioNTech(NASDAQ:BNTX)Holding Weight: 6.18%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 5.54%Laboratory Co. of America(NYSE:LH)Holding Weight: 5.25%ImmunityBio(NASDAQ:IBRX)Holding Weight: 5.21%Novavax(NASDAQ:NVAX)Holding Weight: 4.82%Vaxcyte(NASDAQ:PCVX)Holding Weight: 3.52%QuidelOrtho(NASDAQ:QDEL)Holding Weight: 3.51%Bio-Rad Laboratories(NYSE:BIO)Holding Weight: 3.33%GERM Sector ExposureGERM Industry ExposureFull Holdings Details Similar ETFsTema Neuroscience and Mental Health ETFNASDAQ:MNTLVanEck Robotics ETFNASDAQ:IBOTJPMorgan Active China ETFNYSEARCA:JCHIHartford Longevity Economy ETFNYSEARCA:HLGERoundhill GLP-1 & Weight Loss ETFNASDAQ:OZEM GERM ETF - Frequently Asked Questions How have GERM shares performed in 2024? Amplify Treatments, Testing and Advancements ETF's stock was trading at $19.56 at the start of the year. Since then, GERM shares have increased by 0.0% and is now trading at $19.56. View the best growth stocks for 2024 here. What does GERM invest in? Amplify Treatments, Testing and Advancements ETF is a equity fund issued by Amplify. GERM focuses on theme investments and follows the Prime Treatments, Testing and Advancements Index. The fund's investments total to approximately $10.98 million assets under management. What stocks does Amplify Treatments, Testing and Advancements ETF hold? GERM invests in 57 holdings. Some of the stocks in their portfolio include Moderna (MRNA), Quest Diagnostics (DGX), BioNTech (BNTX), Alnylam Pharmaceuticals (ALNY), Laboratory Co. of America (LH), ImmunityBio (IBRX), Novavax (NVAX), Vaxcyte (PCVX), QuidelOrtho (QDEL) and Bio-Rad Laboratories (BIO). What is the management fee for Amplify Treatments, Testing and Advancements ETF? Amplify Treatments, Testing and Advancements ETF's management fee is 0.68% and has no other recorded expenses or fee waivers. The net expense ratio for GERM is 0.68%. What other stocks do shareholders of Amplify Treatments, Testing and Advancements ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Amplify Treatments, Testing and Advancements ETF investors own include Village Farms International (VFF), Charlotte's Web (CWBHF), 3 Sixty Risk Solutions (PTVYF), Inovio Pharmaceuticals (INO), Moderna (MRNA), PayPal (PYPL), AbbVie (ABBV), Auxly Cannabis Group (CBWTF). How do I buy shares of Amplify Treatments, Testing and Advancements ETF? Shares of GERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:GERM) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Treatments, Testing and Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.